Guangyong Zheng

Dr. Guangyong Zheng


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JCJing Cheng
Jing Cheng
HJHai Jin
Hai Jin
XHXiaobei Hou
Xiaobei Hou
JLJie Lyu
Jie Lyu
XGXianfu Gao
Xianfu Gao
GZGuangyong Zheng
Guangyong Zheng

1 December 2020 in Journal of Experimental Botany
Verified
Journal Article
Closed access
PDF file
FCFaming Chen
Faming Chen
GZGuangyong Zheng
Guangyong Zheng
MQMingnan Qu
Mingnan Qu
YWYanjie Wang
Yanjie Wang
MLMing-Ju Amy Lyu
Ming-Ju Amy Lyu
XZXinguang Zhu
Xinguang Zhu
Improving photosynthesis is a major approach to increase crop yield potential. Here we report a negative transcription factor of photosynthesis, which can be manipulated to increase rice photosynthesis and plant biomass in the field. This transcription factor named negative regulator of photosynthesis 1 (NRP1) (Os07g0471900) which was identified through a co-expression analysis using rice leaf RNA sequencing (RNA-seq) data. The NRP1 showed significantly negative correlation with the expression of many genes involved in photosynthesis. Knocking out NPR1 led to greater photosynthesis and increased biomass in the field, while overexpression of NRP1 decreased photosynthesis and biomass. Transcriptomic data analysis shows that NRP1 can negatively regulate the expression of photosynthetic genes. Protein transactivation experiments show that NRP1 is a transcription activator, implying that NRP1 may indirectly regulate photosynthesis gene expression through an unknown regulator. This study shows that combination of bioinformatics analysis with transgenic testing can be used to identify new regulators to improve photosynthetic efficiency in crops.

1 January 2021 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
JCJing Cheng
Jing Cheng
QLQi Liu
Qi Liu
HJHai Jin
Hai Jin
DZDongdong Zeng
Dongdong Zeng
YLYuehua Liao
Yuehua Liao
GZGuangyong Zheng
Guangyong Zheng

2 September 2023 in BMC Public Health
Verified
Journal Article
Open access
PDF file
JFJingyuan Feng
Jingyuan Feng
HLHongwei Liu
Hongwei Liu
SMShupeng Mai
Shupeng Mai
JSJin Su
Jin Su
JSJing Sun
Jing Sun
ZZZHENNI ZHU
ZHENNI ZHU
Background: Nutrition service needs are huge in China. Previous studies indicated that personalized nutrition (PN) interventions were effective. The aim of the present study is to identify the effectiveness and feasibility of a novel PN approach supported by artificial intelligence (AI). Methods: This study is a two-arm parallel, randomized, controlled trial in real world scenario. The participants will be enrolled among who consume lunch at a staff canteen. In Phase I, a total of 170 eligible participants will be assigned to either intervention or control group on 1:1 ratio. The intervention group will be instructed to use the smartphone applet to record their lunches and reach the real-time AI-based information of dish nutrition evaluation and PN evaluation after meal consumption for 3 months. The control group will receive no nutrition information but be asked to record their lunches though the applet. Dietary pattern, body weight or blood pressure optimizing is expected after the intervention. In phase II, the applet will be free to all the diners (about 800) at the study canteen for another one year. Who use the applet at least 2 days per week will be regarded as the intervention group while the others will be the control group. Body metabolism normalization is expected after this period. Generalized linear mixed models will be used to identify the dietary, anthropometric and metabolic changes. Discussion: This novel approach will provide real-time AI-based dish nutrition evaluation and PN evaluation after meal consumption in order to assist users with nutrition information to make wise food choice. This study is designed under a real-life scenario which facilitates translating the trial intervention into real-world practice. Trial registration: This trial has been registered with the Chinese Clinical Trial Registry (ChiCTR2100051771; date registered: 03/10/2021).

12 May 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
ZZZHENNI ZHU
ZHENNI ZHU
ZWZhengyuan Wang
Zhengyuan Wang
JZJiajie Zang
Jiajie Zang
YLYe Lu
Ye Lu
ZXZiyi Xiao
Ziyi Xiao
FWFan Wu
Fan Wu
This study aimed to explore the role of the single nucleotide polymorphism (SNP) rs516946 of the Ankyrin 1 (ANK1) gene in the relationship between dietary iron and metabolic syndrome (MetS) in the Chinese population. A total of 2766 Chinese adults (1284 males and 1482 females) were recruited. A 3-day 24-h dietary recall and weighing of household condiments were used to assess dietary intake. Anthropometric and laboratory measurements were obtained. After adjusting for age, region, years of education, intentional physical exercise, physical activity level, smoking, alcohol use and energy intake, dietary iron and the SNP rs516946 were both correlated with MetS risk and interacted among the male participants. The trend between dietary iron and MetS risk remained among T allele non-carriers of males but not among T allele carriers of males. Both the SNP rs516946 and the ferritin level correlated positively with the aspartate aminotransferase (AST) level. ANK1 SNP rs516946 interacted in the association of MetS with dietary iron among Chinese males while no association was found among females. Periodic blood loss might prevent females from these associations. The SNP rs516946 might correlate with liver function.

13 April 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
LMLiangxiao Ma
Liangxiao Ma
YLYongxiang Liao
Yongxiang Liao
HFHaiwei Fan
Haiwei Fan
XZXianfeng Zheng
Xianfeng Zheng
JZJintao Zhao
Jintao Zhao
YXYun Xiong
Yun Xiong
Currently, most of the personal health data (PHD) are managed and stored separately by individual medical institutions. When these data need to be shared, they must be transferred to a trusted management center and approved by data owners through the third-party endorsement technology. Therefore, it is difficult for personal health data to be shared and circulated over multiple medical institutions. On the other hand, the use of directly exchanging and sharing the original data has become inconsistent with the data rapid growth of medical institutions because of the need of massive data transferring across agencies. In order to secure sharing and managing the mass personal health data generated by various medical institutions, a federal personal health data management framework (PHDMF, https://hvic.biosino.org/PHDMF) has been developed, which had the following advantages: 1) the blockchain technology was used to establish a data consortium over multiple medical institutions, which could provide a flexible and scalable technical solution for member extension and solve the problem of third-party endorsement during data sharing; 2) using data distributed storage technology, personal health data could be majorly stored in their original medical institutions, and the massive data transferring process was of no further use, which could match up with the data rapid growth of these institutions; 3) the distributed ledger technology was utilized to record the hash value of data, given the anti-tampering feature of the technology, malicious modification of data could be identified by comparing the hash value; 4) the smart contract technology was introduced to manage users’ access and operation of data, which made the data transaction process traceable and solved the problem of data provenance; and 5) a trusted computing environment was provided for meta-analysis with statistic information instead of original data, the trusted computing environment could be further applied to more health data, such as genome sequencing data, protein expression data, and metabolic profile data through combining the federated learning and blockchain technology. In summary, the framework provides a convenient, secure, and trusted environment for health data supervision and circulation, which facilitate the consortium establish over medical institutions and help achieve the value of data sharing and mining.